Skip to main content
. 2024 Mar 23;11(22):2309917. doi: 10.1002/advs.202309917

Figure 1.

Figure 1

Schematic illustration of PD‐L1‐targeted PTEN/Pep LNPs for immunotherapy of TNBC. a) Scheme for the assembly of Pep LNPs with mRNA. b) Targeted delivery of PTEN/Pep LNPs to PD‐L1‐high tumors induces PTEN‐mediated autophagy and ICD, promotes DC maturation, and stimulates CD8+ T cell infiltration, enhancing antitumor immunity.